Your browser doesn't support javascript.
loading
Research Progress of Expression and Clinical Significant of EZH2 in Hematological Malignancies--Review / 中国实验血液学杂志
Journal of Experimental Hematology ; (6): 2097-2012, 2020.
Article in Chinese | WPRIM | ID: wpr-880022
ABSTRACT
Enhancer of zeste homolog 2(EZH2) is a histone methyltransferase which regulate gene expression through epigenetic machinery. The abnormal expression of EZH2 has been described in many cancer types. With in-depth study, it was found that EZH2 is involved in the occurrence and development in many kinds of malignant hematologic disease which may play a dual role of oncogenes and tumor suppressor genes. In recent years, the emergence of EZH2 inhibitors provide a new option for the future treatment of hematological malignancies. In this review, the expression and clinical significance of EZH2 in various of hematological tumors were summarized briefly.
Subject(s)
Full text: Available Index: WPRIM (Western Pacific) Main subject: Oncogenes / Research / Hematologic Neoplasms / Enhancer of Zeste Homolog 2 Protein / Neoplasms Limits: Humans Language: Chinese Journal: Journal of Experimental Hematology Year: 2020 Type: Article

Similar

MEDLINE

...
LILACS

LIS

Full text: Available Index: WPRIM (Western Pacific) Main subject: Oncogenes / Research / Hematologic Neoplasms / Enhancer of Zeste Homolog 2 Protein / Neoplasms Limits: Humans Language: Chinese Journal: Journal of Experimental Hematology Year: 2020 Type: Article